CalciMedica, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: CalciMedica, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q4 2023.
CalciMedica, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was -$32K, a 109% decline year-over-year.
CalciMedica, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $12M, a 759% increase year-over-year.
CalciMedica, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12M, a 759% increase from 2022.
CalciMedica, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.4M, a 73.9% decline from 2021.
CalciMedica, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.38M, a 201% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2023	$12M	-$32K	-$378K	-109%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-28
Q3 2023	$12.4M	$482K	+$83K	+20.8%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$12.3M	$463K	+$142K	+44.2%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$12.2M	$11.1M	+$10.8M	+3221%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$1.4M	$346K	-$1.16M	-77%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$2.56M	$399K	-$1.03M	-72.1%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$3.59M	$321K	-$991K	-75.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	$4.58M	$335K	-$794K	-70.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-12
Q4 2021	$5.38M	$1.5M	+$716K	+91%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-09
Q3 2021	$4.66M	$1.43M	+$870K	+155%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	$3.79M	$1.31M	+$1.1M	+513%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-12
Q1 2021	$2.69M	$1.13M	+$903K	+400%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$1.79M	$787K			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-11
Q3 2020		$561K	+$311K	+124%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020		$214K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020		$226K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q3 2019		$250K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.